|
시장보고서
상품코드
1463133
세계의 검체 타당성 시험 시장 - 점유율, 규모, 동향, 산업 분석 보고서 : 유형별, 제품 및 서비스별, 약물 유형별, 적응증별, 최종 사용자별, 지역별, 부문별 예측(2024-2032년)Specimen Validity Testing Market Share, Size, Trends, Industry Analysis Report, By Type (Laboratory Testing, Rapid/POC Testing); By Product & Service; By Drug Type; By Indication; By End User; By Region; Segment Forecast, 2024 - 2032 |
||||||
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
Polaris Market Research의 최신 조사에 따르면, 검체 타당성 시험 세계 시장 규모는 2032년까지 25억 2,000만 달러에 달할 전망입니다. 이 설문조사 보고서는 현재 시장 역학을 자세히 파악하고 향후 시장 성장에 대한 분석을 제공합니다.
세계 수준의 남용 검사 요구 증가는 시료 타당성 시험 시장의 성장을 크게 뒷받침하고 있습니다. 검체 타당성 시험으로 개인의 약물 섭취 및 기타 음식 섭취를 확인할 수 있는 가능성이 법률이나 법의학 활동에서의 채용을 촉진하고 있습니다. 검체의 변조가 현저하게 증가하고 소변 검체의 보안과 안전성에 대한 우려가 높아지고 있기 때문에 검체 타당성 시험 도구로 검체의 무결성을 확인하는 것이 법 집행관에게 장려되고 있습니다.
불순물 오염, 희석, 변조를 결정하는 기능은 직장, 약물 검사, 형사 사법 시스템 및 세계 시장의 다른 부문에서 채택된 주요 요인입니다. 부정확한 약물 검사 결과는 많은 사람들에게 해를 끼칠 수 있기 때문에 약물 검사의 신뢰성을 결정하기 위한 의학적 검사에 대한 수요가 증가하고 있습니다.
검체 타당성 시험은 항공기, 철도, 자동차 운송업자 및 기타 수송과 같은 규제된 부서의 미묘한 장소에 있는 개인에 대해 널리 실시됩니다. 국민의 안전을 보호하기 위해 효과적인 약물 검사 도구를 채택하는 정부의 이니셔티브는 시장 성장을 가속할 것으로 보입니다. 예를 들어, 2023년 5월, 교통부(DOT)는 소변 검사를 대체하기 위해 경구 약물 검사를 도입했습니다.
직장과 운송에 있어서 안전성을 향상시키기 위한 세계의 엄격한 규제는 시료의 유효성 검사에 다양한 기회를 창출할 것으로 예상됩니다. 게다가, 현재 진행 중인 연구는 합성 소변을 결정하고 새로운 검체 타당성 시험을 창출하기 위한 잠재적 기술을 모색하고 있습니다. 예를 들어, WILEY 잡지에 게재된 2023년 연구에서는 시료 조작 검사에 대한 검토가 이루어졌습니다.
시료 유효성 시험 시장 보고서 하이라이트
소변 검사 서비스를 제공하는 실험실 수가 증가함에 따라 검사실 검사 분야가 가장 높은 성장이 예상됩니다.
제품 부문은 소변 검사 활동의 지속적인 요구에 따라 가장 큰 시장 점유율을 차지합니다.
항바이러스제물 부문은 바이러스 감염의 유행으로 인해 더 큰 수익 점유율을 차지할 것으로 예상됩니다.
아시아태평양에서는 약물 스크리닝 검사의 수가 증가하고 있기 때문에 예측 기간 동안 가장 빠른 성장을 기록할 것으로 예상됩니다.
목차
제1장 서론
제2장 주요 요약
제3장 조사 방법
제4장 세계의 검체 타당성 시험 시장 인사이트
- 검체 타당성 시험 - 업계 스냅샷
- 검체 타당성 시험 시장 역학
- 성장 촉진요인과 기회
- 약물 사용을 완화하기 위한 정부 규제 강화
- 불법 약물의 사용 증가
- 억제요인과 과제
- 대체 약물 스크리닝 검사에 대한 의식 증가
- 성장 촉진요인과 기회
- PESTLE 분석
- 검체 타당성 시험 업계 동향
- COVID-19의 영향 분석
제5장 세계의 검체 타당성 시험 시장, 유형별
- 주요 조사 결과
- 소개
- 임상 검사
- 신속/POC 테스트
제6장 세계의 검체 타당성 시험 시장, 적응증별
- 주요 조사 결과
- 소개
- 혈류 감염증
- 요로 감염증
- 수술 부위 감염
- 폐렴
- 기타
제7장 세계의 검체 타당성 시험 시장, 제품 및 서비스별
- 주요 조사 결과
- 소개
- 제품
- 서비스
제8장 세계의 검체 타당성 시험 시장, 약제 유형별
- 주요 조사 결과
- 소개
- 항균제
- 항진균제
- 항바이러스제
- 기타
제9장 세계의 검체 타당성 시험 시장, 최종 사용자별
- 주요 조사 결과
- 소개
- 약물 스크리닝 연구소
- 통증 관리 센터
- 약물 재활센터
- 직장
- 기타
제10장 세계의 검체 타당성 시험 시장, 지역별
- 주요 조사 결과
- 소개
- 검체 타당성 시험 시장 평가, 지역(2019-2032년)
- 검체 타당성 시험 시장 - 북미
- 북미 : 검체 타당성 시험 시장, 유형별(2019-2032년)
- 북미 : 검체 타당성 시험 시장, 약제 유형별(2019-2032년)
- 북미 : 검체 타당성 시험 시장, 적응증별(2019-2032년)
- 북미 : 검체 타당성 시험 시장, 제품 및 서비스별(2019-2032년)
- 북미 : 검체 타당성 시험 시장, 최종 사용자별(2019-2032년)
- 검체 타당성 시험 시장 - 미국
- 검체 타당성 시험 시장 - 캐나다
- 검체 타당성 시험 시장 - 유럽
- 유럽 : 검체 타당성 시험 시장, 유형별(2019-2032년)
- 유럽 : 검체 타당성 시험 시장, 약제 유형별(2019-2032년)
- 유럽 : 검체 타당성 시험 시장, 적응증별(2019-2032년)
- 유럽 : 검체 타당성 시험 시장, 제품 및 서비스별(2019-2032년)
- 유럽 : 검체 타당성 시험 시장, 최종 사용자별(2019-2032년)
- 검체 타당성 시험 시장 - 영국
- 검체 타당성 시험 시장 - 프랑스
- 검체 타당성 시험 시장 - 독일
- 검체 타당성 시험 시장 - 이탈리아
- 검체 타당성 시험 시장 - 스페인
- 검체 타당성 시험 시장 - 네덜란드
- 검체 타당성 시험 시장 - 러시아
- 검체 타당성 시험 시장 - 아시아태평양
- 아시아태평양 : 검체 타당성 시험 시장, 유형별(2019-2032년)
- 아시아태평양 : 검체 타당성 시험 시장, 약제 유형별(2019-2032년)
- 아시아태평양 : 검체 타당성 시험 시장, 적응증별(2019-2032년)
- 아시아태평양 : 검체 타당성 시험 시장, 제품 및 서비스별(2019-2032년)
- 아시아태평양 : 검체 타당성 시험 시장, 최종 사용자별(2019-2032년)
- 검체 타당성 시험 시장 - 중국
- 검체 타당성 시험 시장 - 인도
- 검체 타당성 시험 시장 - 일본
- 검체 타당성 시험 시장 - 말레이시아
- 검체 타당성 시험 시장 - 인도네시아
- 검체 타당성 시험 시장 - 한국
- 검체 타당성 시험 시장 - 중동 및 아프리카
- 중동 및 아프리카 : 검체 타당성 시험 시장, 유형별(2019-2032년)
- 중동 및 아프리카 : 검체 타당성 시험 시장, 약제 유형별(2019-2032년)
- 중동 및 아프리카 : 검체 타당성 시험 시장, 적응증별(2019-2032년)
- 중동 및 아프리카 : 검체 타당성 시험 시장, 제품 및 서비스별(2019-2032년)
- 중동 및 아프리카 : 검체 타당성 시험 시장, 최종 사용자별(2019-2032년)
- 검체 타당성 시험 시장 - 사우디아라비아
- 검체 타당성 시험 시장 - UAE
- 검체 타당성 시험 시장 - 이스라엘
- 검체 타당성 시험 시장 - 남아프리카
- 검체 타당성 시험 시장 - 라틴아메리카
- 라틴아메리카 : 검체 타당성 시험 시장, 유형별(2019-2032년)
- 라틴아메리카 : 검체 타당성 시험 시장, 약제 유형별(2019-2032년)
- 라틴아메리카 : 검체 타당성 시험 시장, 적응증별(2019-2032년)
- 라틴아메리카 : 검체 타당성 시험 시장, 제품 및 서비스별(2019-2032년)
- 라틴아메리카 : 검체 타당성 시험 시장, 최종 사용자별(2019-2032년)
- 검체 타당성 시험 시장 - 멕시코
- 검체 타당성 시험 시장 - 브라질
- 검체 타당성 시험 시장 - 아르헨티나
제11장 경쟁 구도
- 확대와 인수 분석
- 확대
- 인수
- 파트너십/협업/계약/공개
제12장 기업 프로파일
- Abbott(US)
- Alfa Scientific Designs(US)
- Healgen Scientific LLC(US)
- LabCorp(US)
- Nona Scientific Laboratory(US)
- Omega Laboratories(Canada)
- Premier Biotech, Inc.(US)
- Quest Diagnostics(US)
- Rochester Regional Health(US)
- Sciteck, Inc.(US)
- Siemens Healthineers(Germany)
- Thermo Fisher Scientific(US)
- Vision Diagnostics, Inc.(India)
The global specimen validity testing market size is expected to reach USD 2.52 billion by 2032, according to a new study by Polaris Market Research. The report "Specimen Validity Testing Market Share, Size, Trends, Industry Analysis Report, By Type (Laboratory Testing, Rapid/POC Testing); By Product & Service; By Drug Type; By Indication; By End User; By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The rising need for abuse testing at the global level highly drives the growth of the specimen validity testing market. The potential to identify the individual's drug intake and other food intake with specimen validity testing is facilitating its adoption in legal and forensic science activities. The significant rise in sample tampering and growing concerns about the security and safety of urine samples encouraged legal officers to check the integrity of the sample with specimen validity testing tools.
The capability to determine adulteration, dilution, and tampering is the primary factor contributing to its adoption in the workplace, drug testing, criminal justice system, and other sectors of the global marketplace. As incorrect drug test results can cause harm to several people, there is increasing demand for medical tests to determine the reliability of the drug tests.
Specimen validity testing is widely conducted on individuals in sensitive places in the regulated sector, such as airplanes, rail, motor carriers, and other transits. The government's initiatives to adopt effective drug testing tools to safeguard the population are likely to propel market growth. For instance, in May 2023, the Department of Transportation (DOT) introduced oral drug testing as an alternative to urine testing.
Stringent regulations globally to improve safety at the workplace and in transportation are anticipated to create diverse opportunities for specimen validity testing. Furthermore, ongoing research studies are exploring potential technologies to determine synthetic urine and create new specimen validity testing. For instance, a 2023 study published in WILEY magazine conducted a review on sample manipulation testing.
Specimen Validity Testing Market Report Highlights
The laboratory testing segment is anticipated to witness the highest growth due to the growing number of laboratories providing urine testing services.
The products segment accounted for the largest market share owing to the continuous need for urine testing activities.
The antiviral drugs segment is projected to experience a larger revenue share due to the prevalence of viral infections.
Asia Pacific is projected to register the fastest growth during the forecast period due to the rising number of drug screening tests in the region.
The global players include Abbott, Alfa Scientific Designs, Healgen Scientific, LabCorp, Nona Scientific Laboratory, Omega Laboratories, & Premier Biotech.
Polaris Market Research has segmented the specimen validity testing market report based on product & service, type, drug type, indication, end user and region:
Specimen Validity Testing, Type Outlook (Revenue - USD Billion, 2019 - 2032)
- Laboratory Testing
- Rapid/POC Testing
Specimen Validity Testing, Product & Service Outlook (Revenue - USD Billion, 2019 - 2032)
- Products
- Assay Kits
- Reagents and Calibrators
- Disposables
- Services
Specimen Validity Testing, Drug Type Outlook (Revenue - USD Billion, 2019 - 2032)
- Antibacterial Drugs
- Antifungal Drugs
- Antiviral Drugs
- Others
Specimen Validity Testing, Indication Outlook (Revenue - USD Billion, 2019 - 2032)
- Bloodstream Infections
- Urinary Tract Infections
- Surgical Site Infections
- Pneumonia
- Others
Specimen Validity Testing, End User Outlook (Revenue - USD Billion, 2019 - 2032)
- Drug Screening Laboratories
- Pain Management Centers
- Drug Rehabilitation Centre
- Workplace
- Others
Specimen Validity Testing, Regional Outlook (Revenue - USD Billion, 2019 - 2032)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Netherlands
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Indonesia
- Malaysia
- Australia
- Rest of Asia Pacific
- Latin America
- Argentina
- Brazil
- Mexico
- Rest Latin America
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
- Rest of Middle East & Africa
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Specimen Validity Testing Market Insights
- 4.1. Specimen Validity Testing - Industry Snapshot
- 4.2. Specimen Validity Testing Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Rising government regulations to mitigate drug use
- 4.2.1.2. Increased use of illegal drugs
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Growing awareness about the alternative drug screening tests
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTLE Analysis
- 4.5. Specimen Validity Testing Industry Trends
- 4.6. COVID-19 Impact Analysis
5. Global Specimen Validity Testing Market, by Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
- 5.3. Laboratory Testing
- 5.3.1. Global Specimen Validity Testing Market, by Laboratory Testing, by Region, 2019-2032 (USD Billion)
- 5.4. Rapid/POC Testing
- 5.4.1. Global Specimen Validity Testing Market, by Rapid/POC Testing, by Region, 2019-2032 (USD Billion)
6. Global Specimen Validity Testing Market, by Indication
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
- 6.3. Bloodstream Infections
- 6.3.1. Global Specimen Validity Testing Market, by Bloodstream Infections, by Region, 2019-2032 (USD Billion)
- 6.4. Urinary Tract Infections
- 6.4.1. Global Specimen Validity Testing Market, by Urinary Tract Infections, by Region, 2019-2032 (USD Billion)
- 6.5. Surgical Site Infections
- 6.5.1. Global Specimen Validity Testing Market, by Surgical Site Infections, by Region, 2019-2032 (USD Billion)
- 6.6. Pneumonia
- 6.6.1. Global Specimen Validity Testing Market, by Pneumonia, by Region, 2019-2032 (USD Billion)
- 6.7. Others
- 6.7.1. Global Specimen Validity Testing Market, by Others, by Region, 2019-2032 (USD Billion)
7. Global Specimen Validity Testing Market, by Product & Services
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
- 7.3. Products
- 7.3.1. Global Specimen Validity Testing Market, by Products, by Region, 2019-2032 (USD Billion)
- 7.3.2. Assay Kits
- 7.3.2.1. Global Specimen Validity Testing Market, by Assay Kits, by Region, 2019-2032 (USD Billion)
- 7.3.3. Reagents and Calibrators
- 7.3.3.1. Global Specimen Validity Testing Market, by Reagents and Calibrators, by Region, 2019-2032 (USD Billion)
- 7.3.4. Disposables
- 7.3.4.1. Global Specimen Validity Testing Market, by Disposables, by Region, 2019-2032 (USD Billion)
- 7.4. Services
- 7.4.1. Global Specimen Validity Testing Market, by Services, by Region, 2019-2032 (USD Billion)
8. Global Specimen Validity Testing Market, by Drug Type
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Global Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
- 8.3. Antibacterial Drugs
- 8.3.1. Global Specimen Validity Testing Market, by Antibacterial Drugs, by Region, 2019-2032 (USD Billion)
- 8.4. Antifungal Drugs
- 8.4.1. Global Specimen Validity Testing Market, by Antifungal Drugs, by Region, 2019-2032 (USD Billion)
- 8.5. Antiviral Drugs
- 8.5.1. Global Specimen Validity Testing Market, by Antiviral Drugs, by Region, 2019-2032 (USD Billion)
- 8.6. Others
- 8.6.1. Global Specimen Validity Testing Market, by Others, by Region, 2019-2032 (USD Billion)
9. Global Specimen Validity Testing Market, by End-User
- 9.1. Key Findings
- 9.2. Introduction
- 9.2.1. Global Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
- 9.3. Drug Screening Laboratories
- 9.3.1. Global Specimen Validity Testing Market, by Drug Screening Laboratories, by Region, 2019-2032 (USD Billion)
- 9.4. Pain Management Centers
- 9.4.1. Global Specimen Validity Testing Market, by Pain Management Centers, by Region, 2019-2032 (USD Billion)
- 9.5. Drug Rehabilitation Centre
- 9.5.1. Global Specimen Validity Testing Market, by Drug Rehabilitation Centre, by Region, 2019-2032 (USD Billion)
- 9.6. Workplace
- 9.6.1. Global Specimen Validity Testing Market, by Workplace, by Region, 2019-2032 (USD Billion)
- 9.7. Others
- 9.7.1. Global Specimen Validity Testing Market, by Others, by Region, 2019-2032 (USD Billion)
10. Global Specimen Validity Testing Market, by Geography
- 10.1. Key findings
- 10.2. Introduction
- 10.2.1. Specimen Validity Testing Market Assessment, By Geography, 2019-2032 (USD Billion)
- 10.3. Specimen Validity Testing Market - North America
- 10.3.1. North America: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
- 10.3.2. North America: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
- 10.3.3. North America: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
- 10.3.4. North America: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
- 10.3.5. North America: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
- 10.3.6. Specimen Validity Testing Market - U.S.
- 10.3.6.1. U.S.: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
- 10.3.6.2. U.S.: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
- 10.3.6.3. U.S.: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
- 10.3.6.4. U.S.: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
- 10.3.6.5. U.S.: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
- 10.3.7. Specimen Validity Testing Market - Canada
- 10.3.7.1. Canada: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
- 10.3.7.2. Canada.: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
- 10.3.7.3. Canada: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
- 10.3.7.4. Canada: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
- 10.3.7.5. Canada: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
- 10.4. Specimen Validity Testing Market - Europe
- 10.4.1. Europe: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
- 10.4.2. Europe.: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
- 10.4.3. Europe: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
- 10.4.4. Europe: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
- 10.4.5. Europe: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
- 10.4.6. Specimen Validity Testing Market - UK
- 10.4.6.1. UK: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
- 10.4.6.2. UK.: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
- 10.4.6.3. UK: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
- 10.4.6.4. UK: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
- 10.4.6.5. UK: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
- 10.4.7. Specimen Validity Testing Market - France
- 10.4.7.1. France: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
- 10.4.7.2. France.: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
- 10.4.7.3. France: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
- 10.4.7.4. France: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
- 10.4.7.5. France: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
- 10.4.8. Specimen Validity Testing Market - Germany
- 10.4.8.1. Germany: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
- 10.4.8.2. Germany.: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
- 10.4.8.3. Germany: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
- 10.4.8.4. Germany: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
- 10.4.8.5. Germany: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
- 10.4.9. Specimen Validity Testing Market - Italy
- 10.4.9.1. Italy: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
- 10.4.9.2. Italy.: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
- 10.4.9.3. Italy: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
- 10.4.9.4. Italy: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
- 10.4.9.5. Italy: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
- 10.4.10. Specimen Validity Testing Market - Spain
- 10.4.10.1. Spain: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
- 10.4.10.2. Spain.: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
- 10.4.10.3. Spain: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
- 10.4.10.4. Spain: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
- 10.4.10.5. Spain: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
- 10.4.11. Specimen Validity Testing Market - Netherlands
- 10.4.11.1. Netherlands: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
- 10.4.11.2. Netherlands.: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
- 10.4.11.3. Netherlands: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
- 10.4.11.4. Netherlands: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
- 10.4.11.5. Netherlands: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
- 10.4.12. Specimen Validity Testing Market - Russia
- 10.4.12.1. Russia: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
- 10.4.12.2. Russia.: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
- 10.4.12.3. Russia: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
- 10.4.12.4. Russia: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
- 10.4.12.5. Russia: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
- 10.5. Specimen Validity Testing Market - Asia Pacific
- 10.5.1. Asia Pacific: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
- 10.5.2. Asia Pacific.: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
- 10.5.3. Asia Pacific: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
- 10.5.4. Asia Pacific: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
- 10.5.5. Asia Pacific: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
- 10.5.6. Specimen Validity Testing Market - China
- 10.5.6.1. China: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
- 10.5.6.2. China.: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
- 10.5.6.3. China: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
- 10.5.6.4. China: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
- 10.5.6.5. China: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
- 10.5.7. Specimen Validity Testing Market - India
- 10.5.7.1. India: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
- 10.5.7.2. India.: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
- 10.5.7.3. India: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
- 10.5.7.4. India: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
- 10.5.7.5. India: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
- 10.5.8. Specimen Validity Testing Market - Japan
- 10.5.8.1. Japan: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
- 10.5.8.2. Japan.: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
- 10.5.8.3. Japan: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
- 10.5.8.4. Japan: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
- 10.5.8.5. Japan: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
- 10.5.9. Specimen Validity Testing Market - Malaysia
- 10.5.9.1. Malaysia: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
- 10.5.9.2. Malaysia.: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
- 10.5.9.3. Malaysia: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
- 10.5.9.4. Malaysia: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
- 10.5.9.5. Malaysia: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
- 10.5.10. Specimen Validity Testing Market - Indonesia
- 10.5.10.1. Indonesia: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
- 10.5.10.2. Indonesia.: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
- 10.5.10.3. Indonesia: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
- 10.5.10.4. Indonesia: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
- 10.5.10.5. Indonesia: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
- 10.5.11. Specimen Validity Testing Market - South Korea
- 10.5.11.1. South Korea: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
- 10.5.11.2. South Korea.: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
- 10.5.11.3. South Korea: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
- 10.5.11.4. South Korea: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
- 10.5.11.5. South Korea: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
- 10.6. Specimen Validity Testing Market - Middle East & Africa
- 10.6.1. Middle East & Africa: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
- 10.6.2. Middle East & Africa: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
- 10.6.3. Middle East & Africa: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
- 10.6.4. Middle East & Africa: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
- 10.6.5. Middle East & Africa: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
- 10.6.6. Specimen Validity Testing Market - Saudi Arabia
- 10.6.6.1. Saudi Arabia: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
- 10.6.6.2. Saudi Arabia.: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
- 10.6.6.3. Saudi Arabia: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
- 10.6.6.4. Saudi Arabia: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
- 10.6.6.5. Saudi Arabia: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
- 10.6.7. Specimen Validity Testing Market - UAE
- 10.6.7.1. UAE: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
- 10.6.7.2. UAE.: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
- 10.6.7.3. UAE: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
- 10.6.7.4. UAE: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
- 10.6.7.5. UAE: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
- 10.6.8. Specimen Validity Testing Market - Israel
- 10.6.8.1. Israel: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
- 10.6.8.2. Israel.: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
- 10.6.8.3. Israel: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
- 10.6.8.4. Israel: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
- 10.6.8.5. Israel: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
- 10.6.9. Specimen Validity Testing Market - South Africa
- 10.6.9.1. South Africa: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
- 10.6.9.2. South Africa.: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
- 10.6.9.3. South Africa: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
- 10.6.9.4. South Africa: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
- 10.6.9.5. South Africa: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
- 10.7. Specimen Validity Testing Market - Latin America
- 10.7.1. Latin America: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
- 10.7.2. Latin America.: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
- 10.7.3. Latin America: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
- 10.7.4. Latin America: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
- 10.7.5. Latin America: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
- 10.7.6. Specimen Validity Testing Market - Mexico
- 10.7.6.1. Mexico: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
- 10.7.6.2. Mexico.: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
- 10.7.6.3. Mexico: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
- 10.7.6.4. Mexico: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
- 10.7.6.5. Mexico: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
- 10.7.7. Specimen Validity Testing Market - Brazil
- 10.7.7.1. Brazil: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
- 10.7.7.2. Brazil.: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
- 10.7.7.3. Brazil: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
- 10.7.7.4. Brazil: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
- 10.7.7.5. Brazil: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
- 10.7.8. Specimen Validity Testing Market - Argentina
- 10.7.8.1. Argentina: Specimen Validity Testing Market, by Type, 2019-2032 (USD Billion)
- 10.7.8.2. Argentina.: Specimen Validity Testing Market, by Drug Type, 2019-2032 (USD Billion)
- 10.7.8.3. Argentina: Specimen Validity Testing Market, by Indication, 2019-2032 (USD Billion)
- 10.7.8.4. Argentina: Specimen Validity Testing Market, by Product & Services, 2019-2032 (USD Billion)
- 10.7.8.5. Argentina: Specimen Validity Testing Market, by End-User, 2019-2032 (USD Billion)
11. Competitive Landscape
- 11.1. Expansion and Acquisition Analysis
- 11.1.1. Expansion
- 11.1.2. Acquisitions
- 11.2. Partnerships/Collaborations/Agreements/Exhibitions
12. Company Profiles
- 12.1. Abbott (US)
- 12.1.1. Company Overview
- 12.1.2. Financial Performance
- 12.1.3. Product Benchmarking
- 12.1.4. Recent Development
- 12.2. Alfa Scientific Designs (US)
- 12.2.1. Company Overview
- 12.2.2. Financial Performance
- 12.2.3. Product Benchmarking
- 12.2.4. Recent Development
- 12.3. Healgen Scientific LLC (US)
- 12.3.1. Company Overview
- 12.3.2. Financial Performance
- 12.3.3. Product Benchmarking
- 12.3.4. Recent Development
- 12.4. LabCorp (US)
- 12.4.1. Company Overview
- 12.4.2. Financial Performance
- 12.4.3. Product Benchmarking
- 12.4.4. Recent Development
- 12.5. Nona Scientific Laboratory (US)
- 12.5.1. Company Overview
- 12.5.2. Financial Performance
- 12.5.3. Product Benchmarking
- 12.5.4. Recent Development
- 12.6. Omega Laboratories (Canada)
- 12.6.1. Company Overview
- 12.6.2. Financial Performance
- 12.6.3. Product Benchmarking
- 12.6.4. Recent Development
- 12.7. Premier Biotech, Inc. (US)
- 12.7.1. Company Overview
- 12.7.2. Financial Performance
- 12.7.3. Product Benchmarking
- 12.7.4. Recent Development
- 12.8. Quest Diagnostics (US)
- 12.8.1. Company Overview
- 12.8.2. Financial Performance
- 12.8.3. Product Benchmarking
- 12.8.4. Recent Development
- 12.9. Rochester Regional Health (US)
- 12.9.1. Company Overview
- 12.9.2. Financial Performance
- 12.9.3. Product Benchmarking
- 12.9.4. Recent Development
- 12.10. Sciteck, Inc. (US)
- 12.10.1. Company Overview
- 12.10.2. Financial Performance
- 12.10.3. Product Benchmarking
- 12.10.4. Recent Development
- 12.11. Siemens Healthineers (Germany)
- 12.11.1. Company Overview
- 12.11.2. Financial Performance
- 12.11.3. Product Benchmarking
- 12.11.4. Recent Development
- 12.12. Thermo Fisher Scientific (US)
- 12.12.1. Company Overview
- 12.12.2. Financial Performance
- 12.12.3. Product Benchmarking
- 12.12.4. Recent Development
- 12.13. Vision Diagnostics, Inc. (India)
- 12.13.1. Company Overview
- 12.13.2. Financial Performance
- 12.13.3. Product Benchmarking
- 12.13.4. Recent Development
비교리스트